Linked Life Data

16752713

Source:http://linkedlifedata.com/resource/pubmed/id/16752713

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2006-6-6
pubmed:abstractText
Recently, the Food and Drug Administration approved implantable left ventricular assist devices (LVAD) as destination therapy (DT) for end-stage heart failure patients who are ineligible for cardiac transplantation.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
0029-2559
pubmed:author
pubmed:issnType
Print
pubmed:volume
67
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
110-5
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:articleTitle
Implantable left ventricular assist devices: new hope for patients with end-stage heart failure.
pubmed:affiliation
Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA. milan002@mc.duke.edu
pubmed:publicationType
Journal Article